Insights › Market reaction

Why Zura Bio (ZURA) Stock Fell 69.06% in 10 Minutes on Nov 9, 2026

1.07 million shares changed hands in those 10 minutes, 809.0 times the stock's normal volume for that stretch of the session.

Published in ET: Feed time in ET: Company news ZURA -69.06% in 10 min after the headline
  • ZURA fell 69.06% in the 10 minutes after the 07:00:02 ET headline, from $4.20 to $1.30.
  • The headline crossed in pre-market trading, 2 hours 30 minutes before the 9:30 ET open.
  • The first-minute move held: -76.57% at one minute, -69.06% at 10 minutes.
ZURA Why Zura Bio (ZURA) Stock Fell 69.06% in 10 Minutes on Nov 9, 2026
MoveSurge publish 07:00:02 ET
MoveSurge publish
07:00:02 ET
4.46 3.20 1.89 0.63 1.37 06:58 07:00 07:20
Real 1-minute OHLC candles around publish time. Chart times are New York ET; validated market data captured by MoveSurge.

Reaction by asset (real prices)

Asset2m beforeAt release+1m+10m+1m %+10m %
ZURA
Volume 809.0× normal in 15 min
4.20 4.20 0.98 1.30 -76.57% -69.06%

Zura Bio (ZURA) shares fell 69.06% in the 10 minutes after this headline reached the MoveSurge news feed at 07:00:02 ET on Monday, November 9, 2026: “Zura Bio provides a clinical update on its Phase 2 TibuShield study of tibulizumab (ZB-106) in hidradenitis suppurativa”

ZURA in the first 10 minutes

From a reference price of $4.20 just before the headline, the stock was down 76.57% after one minute and down 69.06%, at $1.30, after 10 minutes. The first-minute move held. 1.07 million shares changed hands in those 10 minutes, 809.0 times the stock's normal volume for that stretch of the session. The headline crossed in pre-market trading, 2 hours 30 minutes before the 9:30 ET open.

Other ZURA headlines on November 9, 2026

  • 07:07 ET: “Zura Bio (ZURA) 8-K: Phase 2 trial missed its primary endpoint (Item 8.01)” (+25.22% in 10 minutes)

Zura Bio at a glance

SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Market value$362 million (as of Nov 9, 2026)

Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.

What headline moved Zura Bio stock on November 9, 2026?

At 07:00:02 ET, this headline crossed: “Zura Bio provides a clinical update on its Phase 2 TibuShield study of tibulizumab (ZB-106) in hidradenitis suppurativa”. The stock fell 69.06% in the next 10 minutes.

How far did ZURA move after the headline?

From $4.20 just before the headline to $1.30 10 minutes later, a -69.06% move.

Sources

Never miss the next market-moving story

Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.

Go live — 7 days for $29 Watch live headlines -- free
See live news
The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.